| Nov 8 |
Crescita Therapeutics Third Quarter 2024 Earnings: CA$0.054 loss per share (vs CA$0.063 loss in 3Q 2023)
|
| Nov 6 |
Crescita Reports Third Quarter 2024 Results
|
| Sep 24 |
Crescita Therapeutics Announces Approval of Normal Course Issuer Bid
|
| Sep 24 |
Keynotes and 50 Companies to Present at the Planet MicroCap Showcase: VANCOUVER in association with Small Cap Discoveries on September 25-26, 2024 at the Fairmont Waterfront Vancouver
|
| Sep 12 |
Crescita to Present & Participate in 1x1 Meetings at the Planet MicroCap Showcase: VANCOUVER 2024 in Association with Small Cap Discoveries on Thursday, September 26, 2024
|
| Aug 7 |
Crescita Therapeutics Down 4.5% As Reports Wider Q2 Net Loss On Lower Revenues
|
| Aug 7 |
Crescita Reports Second Quarter 2024 Results
|
| Jul 22 |
Crescita Therapeutics Secures US$10 Million, 4-Year Manufacturing Contract
|
| Jul 22 |
Crescita Secures Contract Manufacturing Revenue of $US10 Million Over 4 Years
|
| Jul 19 |
Leading Canadian Healthcare Services Provider Selects Crescita as Exclusive Manufacturing Partner under 5-Year Agreement
|
